Nearly 90 per cent of cases of cervical cancer are caused by the human papillomavirus (HPV), which spreads primarily through ...
Schools will require parental consent before vaccinating students, and a public awareness drive will also be launched, ...
Pharmaceutical Technology on MSN9d
Curevo procures $110m and former-GSK exec for shingles vaccine candidateCurevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...
Slaoui spent nearly 30 years at the big pharma, helping develop vaccines such as HPV-induced cervical cancer vaccine Cervarix (human papillomavirus bivalent vaccine) and malaria jab Mosquirix (RTS ...
Dr. Slaoui contributed to the development of many vaccines during his nearly 30 years at GSK, including Shingrix (shingles), Cervarix (cervical cancer), Rotarix (rotavirus), and Synflorix ...
Similarly, the vaccine market has seen launches like Mercks’ Gardasil and GSK’s Cervarix which are under patent. Pfizer also recently launched Prevnar-13 under Wyeth which has the potential to ...
The Business Research Company The Business Research Company’s Cervarix Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 2025 Market Reports Released: Trends, Forecasts t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback